The Real Reason Samsung Electronics and SK Hynix Stock Prices Plunged, and the True Intentions Behind Foreigners' KOSPI Trades

[#UrgentMarketUpdate] The Real Reason Samsung Electronics, SK Hynix Stock Prices Plummeted. / KOSPI, Why are Foreigners Buying and Selling? The Real Intention is 'This' | CEO Lee Gwon-hee
Watch on YouTube ↗  |  August 06, 2026 at 07:00  |  18:02  |  815 Money Talk (815머니톡)
Speakers
Lee Kwon-hee — CEO, Economist
Park Geun-hyung — Director

Summary

Lee Gwon-hee, CEO of Wizwave, analyzes the sharp drop in Samsung Electronics and SK Hynix, attributing it to aggressive foreign short futures positioning and disappointment over vague shareholder return timelines. Despite index weakness, he highlights positive momentum in non-ferrous metals fueled by copper, a recovering South Korean biotech sector driven by Alteogen’s royalty surge, and defensive rotation into high-dividend financials. He also notes strength in defense, Samyang Foods, and medical aesthetics stock PharmaResearch, while cautioning that the market remains volatile and earnings-sensitive in August.

  • Foreign investors are adding short futures and selling Samsung Electronics and SK Hynix, with delayed buyback announcements magnifying the decline.
  • Despite KOSPI weakness, more than half of listed stocks are rising, signaling a rotation into stock-picking.
  • Copper price surge and thorium interest lift non-ferrous metal stocks like Korea Zinc, Poongsan, and JS Link.
  • US biotech index breakout supports a Korean biotech recovery, with Alteogen benefiting from faster CUREX royalties and upcoming milestones.
  • Defensive buying pushes up high-dividend financial holding companies (Hana, Shinhan, Meritz) and DB Insurance.
  • Samyang Foods benefits from export growth and Palantir collaboration, while PharmaResearch approaches a record-earnings breakout.
  • Defense stocks and PCB substrate names like Simek are rebounding technically but remain in early recovery.
Ideas
Lee Kwon-hee CEO, Economist 3:59
Copper rally lifts non-ferrous metal stocks.
Copper price surge is driving interest in non-ferrous metal stocks; related companies are showing strong upward trends, with Korea Zinc surging on good earnings and Poongsan, Sam-A Aluminum also performing well.
Lee Kwon-hee CEO, Economist 4:20
Thorium demand pushes JS Link higher.
JS Link is a company with a rare earth/thorium research magnet business that is rising due to renewed thorium interest; it plans US expansion and has a decent market cap around 1.3 trillion won, showing unusual strength for a KOSDAQ mid-cap.
Lee Kwon-hee CEO, Economist 5:33
Defense stocks rebounding from lows.
Defense stocks are rebounding from their lows, with Hanwha Aerospace leading and smaller names like RF Materials rising sharply; the sector has been climbing for over a week and is showing a recovery trend.
Lee Kwon-hee CEO, Economist 6:00
Financials rise on defensive rotation.
Market uncertainty and the sharp drop in Samsung Electronics and SK Hynix are prompting a rotation into high-dividend financial holding companies; stocks like Hana Financial Group, Shinhan Financial Group, Meritz Financial Group, and DB Insurance are rising as defensive plays.
Lee Kwon-hee CEO, Economist 6:22
Samyang Foods benefits from export growth.
Samyang Foods is collaborating with Palantir for factory efficiency, exports are strong, and earnings expectations are high; the company is becoming more attractive as a food export play.
Lee Kwon-hee CEO, Economist 7:33
Alteogen royalties and milestones surge.
Alteogen is seeing much faster CUREX penetration than analysts expected, with royalties potentially reaching 100 billion won; three clinical milestones have started, improving cash flow dramatically, and the stock could rally strongly from current levels.
Lee Kwon-hee CEO, Economist 11:44
Korean biotech sector recovers.
The US biotech index is breaking out to fresh highs, while Korean biotech lagged in June-July; now the Korean biotech sector is recovering, led by Alteogen's catalysts and other beaten-down names rebounding.
Lee Kwon-hee CEO, Economist 14:45
PCB demand supports Simek, TLB rebound.
PCB substrate demand is strong, as evidenced by Japanese Ibiden's earnings, and Korean names like Simek and TLB are attracting order flow; although still a technical rebound, there is potential for further upside if the trend continues.
Lee Kwon-hee CEO, Economist 16:27
PharmaResearch hits record earnings soon.
PharmaResearch is showing perfect market share and earnings growth trajectory, with a very high probability of record quarterly earnings in Q2; the stock is testing 400,000 won and could gain momentum if this resistance is broken.
Up Next

This 815 Money Talk (815머니톡) video, published August 06, 2026, features Lee Kwon-hee discussing 010130.KS, 006110.KS, 103140.KS, JS Link, 327260.KQ, 012450.KS, 005830.KS, 055550.KS, 086790.KS, 138040.KS, 003230.KS, 196170.KQ, Korean biotech sector, 139780.KQ, 222800.KQ, 214450.KQ. 9 trade ideas extracted by AI with direction and confidence scoring.

Speakers: Lee Kwon-hee  · Tickers: 010130.KS, 006110.KS, 103140.KS, JS Link, 327260.KQ, 012450.KS, 005830.KS, 055550.KS, 086790.KS, 138040.KS, 003230.KS, 196170.KQ, Korean biotech sector, 139780.KQ, 222800.KQ, 214450.KQ